Viral genome changes and the impact of viral genome persistence in myocardium of patients with inflammatory cardiomyopathy
- PMID: 30393478
- PMCID: PMC6209701
- DOI: 10.5114/aoms.2018.79002
Viral genome changes and the impact of viral genome persistence in myocardium of patients with inflammatory cardiomyopathy
Abstract
Introduction: Viral infections are considered the most frequent cause of myocarditis and dilated cardiomyopathy (DCM).
Material and methods: We investigated the changes in viral presence and the impact of viral genome persistence in the myocardium on echocardiographic parameters, functional status and some laboratory parameters in a 6-month follow-up. Fifty-four patients with recent onset DCM, left ventricular ejection fraction < 40% and biopsy-proven myocarditis (> 14 mononuclear leukocytes/mm2 and/or > 7 T-lymphocytes/mm2) were enrolled. Polymerase chain reaction (PCR) was performed to detect pathogens in the myocardium. Patients were divided according to the administered therapy: standard heart failure medication (46 patients) and immunosuppressive therapy (8 patients).
Results: In the standard heart failure medication group viral clearance was observed in 13 patients and viral persistence in 24 patients in the follow-up period. Comparing both groups, there was no statistically significant difference - LVEF improvement of 12.0 ±11.4% vs. 18.3 ±12.6%, decrease in NYHA class of 0.7 ±0.7 vs. 1.0 ±0.7, decline in NT-proBNP of 1335 ±1933 ng/l vs. 1942 ±3242 ng/l and decrease in infiltrating leukocytes of 11.1 ±15.8 vs. 6.7 ±23.0 cells/mm2 and T-lymphocytes of 5.8 ±15.1 vs. 1.8 ±10.9 cells/mm2 (all p = NS). A decrease in PCR positive patients from 37 to 29 was observed. The number of PVB19 positive PCR findings decreased from 5 to 4 in patients with immunosuppressive therapy.
Conclusions: A decrease in the number of positive PCR findings in control endomyocardial biopsy was observed. Viral genome persistence was not associated with worse outcome in short-term follow-up.
Keywords: dilated cardiomyopathy; endomyocardial biopsy; inflammatory cardiomyopathy; myocarditis; polymerase chain reaction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.Heart Vessels. 2016 Mar;31(3):416-26. doi: 10.1007/s00380-014-0618-0. Epub 2014 Dec 25. Heart Vessels. 2016. PMID: 25539624
-
Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.Antivir Ther. 2010;15(2):193-201. doi: 10.3851/IMP1516. Antivir Ther. 2010. PMID: 20386074 Clinical Trial.
-
Detection of viral and bacterial protein in endomyocardial biopsies of patients with inflammatory heart muscle disease?Herz. 2000 May;25(3):233-9. doi: 10.1007/s000590050012. Herz. 2000. PMID: 10904844
-
Inflammatory dilated cardiomyopathy (DCMI).Herz. 2005 Sep;30(6):535-44. doi: 10.1007/s00059-005-2730-5. Herz. 2005. PMID: 16170686 Review.
-
Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.Herz. 2004 Sep;29(6):624-36. doi: 10.1007/s00059-004-2628-7. Herz. 2004. PMID: 15912438 Review.
Cited by
-
Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection-Systematic Review.Int J Mol Sci. 2024 Jul 25;25(15):8127. doi: 10.3390/ijms25158127. Int J Mol Sci. 2024. PMID: 39125696 Free PMC article.
-
Transgenic Mice Expressing Functional TCRs Specific to Cardiac Myhc-α 334-352 on Both CD4 and CD8 T Cells Are Resistant to the Development of Myocarditis on C57BL/6 Genetic Background.Cells. 2023 Sep 25;12(19):2346. doi: 10.3390/cells12192346. Cells. 2023. PMID: 37830560 Free PMC article.
-
Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy.Arch Med Sci. 2019 Nov 18;18(2):480-488. doi: 10.5114/aoms.2019.89777. eCollection 2022. Arch Med Sci. 2019. PMID: 35316894 Free PMC article.
References
-
- Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. J Heart Lung Transplant. 2010;29:1089–103. - PubMed
-
- Cooper LT. The heat is off: immunosuppression for myocarditis revisited. Eur Heart J. 2009;30:1936–9. - PubMed
-
- Krejci J, Poloczkova H, Hude P, et al. Impact of inflammatory infiltration and viral genome presence in myocardium on the changes of echocardiographic parameters. Cor et Vasa. 2013;4:e333–40.
-
- Kühl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005;111:887–93. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous